Cargando…
NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis
Autores principales: | Kondylis, Vangelis, Polykratis, Apostolos, Ehlken, Hanno, Ochoa-Callejero, Laura, Straub, Beate Katharina, Krishna-Subramanian, Santosh, Van, Trieu-My, Curth, Harald-Morten, Heise, Nicole, Weih, Falk, Klein, Ulf, Schirmacher, Peter, Kelliher, Michelle, Pasparakis, Manolis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628166/ https://www.ncbi.nlm.nih.gov/pubmed/28843278 http://dx.doi.org/10.1016/j.ccell.2015.11.007 |
Ejemplares similares
-
NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis
por: Kondylis, Vangelis, et al.
Publicado: (2015) -
Smooth muscle cell specific NEMO deficiency inhibits atherosclerosis in ApoE(−/−) mice
por: Imai, Takashi, et al.
Publicado: (2022) -
NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions
por: Vlantis, Katerina, et al.
Publicado: (2016) -
Hepatocyte IKK2 Protects Mdr2(−/−) Mice from Chronic Liver Failure
por: Ehlken, Hanno, et al.
Publicado: (2011) -
p62 Promotes Survival and Hepatocarcinogenesis in Mice with Liver-Specific NEMO Ablation
por: Kondylis, Vangelis, et al.
Publicado: (2022)